Apoptosis induction and cytolytic effects of Newcastle Disease Virus strain Af224O on DBTRG.O5 mg brain tumor cell line

International Journal of Cancer Research

Volumn 7, Issue 1, 2011, Pages 25-35

  Ali, Rola ^a   Alabsi, Aied M ^b   Ali, Abdual Manaf ^b   Ainideris, ^a   Omar, Abdual Rahamn ^a   Yousoff, Khatijah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

Author keywords

Apoptosis; Cytotoxicity; DNA damage; Flow cytometry; Glioblastoma multiforme; NDV

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOCORTIN 5; NEWCASTLE DISEASE VIRUS AF2240 STRAIN; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CELL; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NICK END LABELING; NONHUMAN; ONCOLYTIC VIROTHERAPY; VIRUS DNA CELL DNA INTERACTION; VIRUS TITRATION;

EID: 79959308449     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2011.25.35     Document Type: Article

References (29)

1. Alexander, D.J., 1988. Newcastle Disease Diagnosis. In: Newcastle Disease, Alexander, D.J. (Ed.). Kluwer Academic Publishers, Norwell, Massachusetts, ISBN: 0-89838-392-7, pp: 147-160.
2. Aubry, J.P., A. Blaecke, S. Lecoanet-Henchoz, P. Jeannin and N. Herbault et al., 1999. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry, 37: 197-204.
3. Chambers, P. and A.C.R. Samson, 1980. A new structural protein for newcastle disease virus. J. General Virol., 50: 155-166.
4. Everts, B. and H.G. van der Poel, 2005. Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther., 12: 141-161.
5. Freeman, A.I., Z. Zakay-Rones, J.M. Gomori, E. Linetsky and L. Rasooly et al., 2006. Phase I/I I trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol. Ther., 13: 221-228.
6. Fried, J., A.G. Perez and B.D. Clarkson, 1976. Flow cytofluorometric analysis of cell cycle distributions using propidium iodide, Properties of the method and mathematical analysis of the data. J. Cell Biol., 71: 172-181.
7. Gao, N., M.J. Keane, T. Ong, J. Ye, W.E. Miller and W.E. Wallace, 2001. Effects of phospholipid surfactant on apoptosis induction by respirable quartz and kaolin in NR8383 rat pulmonary. Toxicol. Applied Pharmacol., 175: 217-225.
8. Gavrieli, Y., Y. Sherman and S.A. Ben-Sasson, 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501.
9. Henson, J.W., 1999. Glioblastoma multiforme and anaplastic glioma: A patient guide. http://brain.mgh.harvard.edu/PatientGuide.htm.
10. Lin, W.L., G.D. Li, Q. Chen and H.M. Lu, 2004. Clinical and experimental study of oxaliplatin in treating human gastric carcinoma. World J. Gastroenterol., 19: 2911-2915.
11. Lorence, R.M., K.W. Richard, B.B. Katubig, H.M. Reyes and A. Phuangsab et al., 1994. Complete regression of human neuroblastoma xenographts in athimic mice after local Newcastle disease virus therapy. J. Natl. Cancer Inst., 86: 1228-1233.
12. Mangiardi, J.R. and H. Kane, 2003. A, B, Cs of brain tumors-from their biology to their treatments. http://www.brain-surgery.com/primer.html.
13. Meyyappan, M., 2003. Oncolytic effect of Newcastle disease virus on the MCF-7 and MDA-231 breast cancer cell lines. Master Thesis, Universiti Putra Malaysia, Malaysia.
14. Nicoletti, I., G. Migliorati, M.C. Pagliacci, F. Grignani and C. Riccardi, 1991. A rapid and simple method for measuring thymocyte apoptosis by Propidium iodide staining and flow cytometry. J. Immunol. Meth., 139: 271-279.
15. Niederhuber, J.E., 2006. Questions and answers about Newcastle disease virus. http://www.cancer.gov/cancertopics/pdq/cam/NDV/Patient/page2.
16. Omar, A., A. Ideris, A.M. Ali, F. Othman and K. Yussoff et al., 2003. An overview on the development of Newcastle disease virus as an anti-cancer therapy. Malaysian J. Med. Sci., 10: 4-12.
17. Othman, F., A. Ideris, G. Motalleb, Z.B. Eshakabd A. Rahmat, 2010. Oncolytic effect of newcastle disease virus AF2240 strain on the MCF-7 breast cancer cell line. Yakhteh Med. J., 12: 17-24.
18. Reichard, K.W., R.M. Lorence, C.J. Cascino, M.E. Peeples and R.J. Walter et al., 1992. Newcastle disease virus selectively kills human tumor cells. J. Surg. Res., 52: 448-453.
19. Stahelin, B.J., U. Marti, M. Solioz, H. Zimmermann and J. Reichen, 1998. False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. Mol. Pathol., 51: 204-208.
20. Stupp, R., W.P. Mason, M.J. van den Bent, M. Weller and B. Fisher et al., 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England J. Med., 352: 987-996.
21. Szeberenyi, J., Z. Fabian, B. Torocsik, K. Kiss and L.K. Csatary, 2003. Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells. Am. J. Therapeutics, 10: 282-288.
22. Telford, W.G., L.E. King and P.J. Fraker, 1994. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J. Immunological Methods, 172: 1-16.
23. Van Engeland, M., L.J. Nieland, F.C. Ramaekers, B. Schutte and C.P. Reutelingsperger, 1998. Annexin Y-Affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 31: 1-9.
24. Vermes, I., C. Haanen, H. Steffens-Nakken and C. Reutelingsperger, 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods, 184: 39-51.
25. Wali, H.S.M., 2003. The effects of Newcastle Disease Virus (NDV) on breast cancer cell lines. Master Thesis, Universiti Putra Malaysia, Malaysia.
26. Yasuhara, S., Y. Zhu, T. Matsui, N. Tipirneni and Y. Yasuhara et al., 2003. Comparison of comet assay, electron microscopy and flow cytometry for detection of apoptosis. J. Histochem. Cytochem., 51: 873-885.
27. You, L., B. He, Z. Xu, F. McCormick and D.M. Jablons, 2004. Future directions: Oncolytic viruses. Clin. Lung Cancer, 5: 226-230.
28. Yusoff, K., W.S. Tan, C.H. Lau, B.K. Ng and A.L. Ibrahim, 1996. Sequence of the haemagglutinin-neuraminadase gene of the Newcastle disease virus oral vaccine strain V4 (UPM). Avian Pathol., 25: 837-844.
29. Zawawi, M., 2006. Cytolytic effect of Newcastle disease virus strain V4 (UPM) on leukemic cell lines CEM-SS and HL6O. Master Thesis, Universiti Putra Malaysia, Malaysia.